Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Anemia

  Free Subscription


Articles published in Leukemia

Retrieve available abstracts of 21 articles:
HTML format



Single Articles


    October 2022
  1. PAGLIUCA S, Gurnari C, Hercus C, Hergalant S, et al
    Molecular landscape of immune pressure and escape in aplastic anemia.
    Leukemia. 2022 Oct 17. pii: 10.1038/s41375-022-01723.
    PubMed     Abstract available


    September 2022
  2. MESA R, Harrison C, Oh ST, Gerds AT, et al
    Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosis.
    Leukemia. 2022;36:2261-2268.
    PubMed     Abstract available


    August 2022
  3. KELKKA T, Tyster M, Lundgren S, Feng X, et al
    Anti-COX-2 autoantibody is a novel biomarker of immune aplastic anemia.
    Leukemia. 2022 Aug 5. pii: 10.1038/s41375-022-01654.
    PubMed     Abstract available


    July 2022
  4. GROARKE EM, Patel BA, Shalhoub R, Gutierrez-Rodrigues F, et al
    Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemia.
    Leukemia. 2022 Jul 27. pii: 10.1038/s41375-022-01636.
    PubMed     Abstract available


    May 2022
  5. HUANG Y, Chen M, Yang C, Ruan J, et al
    Sirolimus is effective for refractory/relapsed/intolerant acquired pure red cell aplasia: results of a prospective single-institutional trial.
    Leukemia. 2022;36:1351-1360.
    PubMed     Abstract available


  6. KOMROKJI RS, Platzbecker U, Fenaux P, Zeidan AM, et al
    Luspatercept for myelodysplastic syndromes/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.
    Leukemia. 2022;36:1432-1435.
    PubMed    


    April 2022
  7. TSUJI N, Hosokawa K, Urushihara R, Tanabe M, et al
    Frequent HLA-DR loss on hematopoietic stem progenitor cells in patients with cyclosporine-dependent aplastic anemia carrying HLA-DR15.
    Leukemia. 2022 Apr 26. pii: 10.1038/s41375-022-01549.
    PubMed     Abstract available


  8. SWOBODA DM, Kanagal-Shamanna R, Brunner AM, Cluzeau T, et al
    Marrow ring sideroblasts are highly predictive for TP53 mutation in MDS with excess blasts.
    Leukemia. 2022;36:1189-1192.
    PubMed    


    January 2022
  9. LIN Q, Lian J, Wu J, Meng P, et al
    Erythropoietin receptor contributes to thrombopoietin receptor (Mpl)-independent thrombocytopoiesis in zebrafish.
    Leukemia. 2022 Jan 18. pii: 10.1038/s41375-021-01495.
    PubMed    


    October 2021
  10. ZHOU C, Kuang M, Liu Z, Jia X, et al
    Insufficiency of FZR1 disturbs HSC quiescence by inhibiting ubiquitin-dependent degradation of RUNX1 in aplastic anemia.
    Leukemia. 2021 Oct 11. pii: 10.1038/s41375-021-01445.
    PubMed     Abstract available


    September 2021
  11. CERVANTES F, Ross DM, Radinoff A, Palandri F, et al
    Correction: Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study.
    Leukemia. 2021 Sep 2. pii: 10.1038/s41375-021-01396.
    PubMed    


    August 2021
  12. FEURSTEIN S, Churpek JE, Walsh T, Keel S, et al
    Germline variants drive myelodysplastic syndrome in young adults.
    Leukemia. 2021;35:2439-2444.
    PubMed    


  13. GURNARI C, Pagliuca S, Patel BJ, Awada H, et al
    Implication of PIGA genotype on erythrocytes phenotype in Paroxysmal Nocturnal Hemoglobinuria.
    Leukemia. 2021;35:2431-2434.
    PubMed    


    June 2021
  14. GURNARI C, Durrani J, Pagliuca S, Kishtagari A, et al
    Novel invariant features of Good syndrome.
    Leukemia. 2021;35:1792-1796.
    PubMed    


    May 2021
  15. CERVANTES F, Ross DM, Radinoff A, Palandri F, et al
    Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study.
    Leukemia. 2021 May 20. pii: 10.1038/s41375-021-01261.
    PubMed     Abstract available


    April 2021
  16. YOROIDAKA T, Hosokawa K, Imi T, Mizumaki H, et al
    Hematopoietic stem progenitor cells lacking HLA differ from those lacking GPI-anchored proteins in the hierarchical stage and sensitivity to immune attack in patients with acquired aplastic anemia.
    Leukemia. 2021 Apr 6. pii: 10.1038/s41375-021-01202.
    PubMed     Abstract available


  17. ZHANG L, Chen JY, Kerr C, Cobb BA, et al
    Reduced red blood cell surface level of Factor H as a mechanism underlying paroxysmal nocturnal hemoglobinuria.
    Leukemia. 2021;35:1176-1187.
    PubMed     Abstract available


    March 2021
  18. LUNDGREN S, Keranen MAI, Kankainen M, Huuhtanen J, et al
    Somatic mutations in lymphocytes in patients with immune-mediated aplastic anemia.
    Leukemia. 2021 Mar 30. pii: 10.1038/s41375-021-01231.
    PubMed     Abstract available


  19. SEYFRIED AN, McCabe A, Smith JNP, Calvi LM, et al
    CCR5 maintains macrophages in the bone marrow and drives hematopoietic failure in a mouse model of severe aplastic anemia.
    Leukemia. 2021 Mar 20. pii: 10.1038/s41375-021-01219.
    PubMed     Abstract available


  20. FATTIZZO B, Ireland R, Dunlop A, Yallop D, et al
    Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia.
    Leukemia. 2021 Mar 4. pii: 10.1038/s41375-021-01190.
    PubMed     Abstract available


    November 2020
  21. SPORTOLETTI P, Sorcini D, Guzman AG, Reyes JM, et al
    Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice.
    Leukemia. 2020 Nov 6. pii: 10.1038/s41375-020-01075.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: